Spanish Red Biotech Pipeline

Amgen

apremilast

Type: Biodrugs/ Drugs
Therapeutic area: Dermatology
Musculoskeletal Disorders
Indication: Juvenile psoriatic arthritis
Phase: 3Phase III in Spain, 2Phase II, 1Phase I